About Akers Nanotechnology
Company Overview
Akers Nanotechnology is a leading global rapid diagnostic test developer and supplier, and vaccine and pharmaceutical supplier.
COVID-19 & Infectious Diseases: Akers Nanotechnology provides the products and services required for your mission to beat COVID-19. We're doing our part in the fight against COVID-19 by supplying globally COVID-19 Vaccines, Rapid COVID-19 Tests, Pharmaceuticals, and Flu Vaccines.
Nanotechnology for a Healthier Lifestyle: We design and manufacture mobile health tests (mHealthTests™) which provide instant information on health and metabolism that enables healthy lifestyle choices based on our proprietary nanotechnology and digital application platforms.
Our seasoned, veteran management team has been working together for over 40 years.
We have a global footprint and strategic partners in commercial, government, and military markets.
We have a distinct record of innovation and success in the rapid medical diagnostics industry. We have developed, patented, and commercialized numerous unique rapid diagnostic tests, including for infectious diseases, sexually transmitted diseases, drugs of abuse, alcohol, and adverse drug reactions.
We are a leader in the personal healthcare revolution of the Internet of Medical Things, and our extensive experience in the medical diagnostics industry, combined with new, cutting-edge nanotechnology platforms, positions us to accomplish just that.
The Company manufactures its products at its facilities and with subcontractors.
COVID-19 & Infectious Diseases: Akers Nanotechnology provides the products and services required for your mission to beat COVID-19. We're doing our part in the fight against COVID-19 by supplying globally COVID-19 Vaccines, Rapid COVID-19 Tests, Pharmaceuticals, and Flu Vaccines.
Nanotechnology for a Healthier Lifestyle: We design and manufacture mobile health tests (mHealthTests™) which provide instant information on health and metabolism that enables healthy lifestyle choices based on our proprietary nanotechnology and digital application platforms.
Our seasoned, veteran management team has been working together for over 40 years.
We have a global footprint and strategic partners in commercial, government, and military markets.
We have a distinct record of innovation and success in the rapid medical diagnostics industry. We have developed, patented, and commercialized numerous unique rapid diagnostic tests, including for infectious diseases, sexually transmitted diseases, drugs of abuse, alcohol, and adverse drug reactions.
We are a leader in the personal healthcare revolution of the Internet of Medical Things, and our extensive experience in the medical diagnostics industry, combined with new, cutting-edge nanotechnology platforms, positions us to accomplish just that.
The Company manufactures its products at its facilities and with subcontractors.
Raymond F. Akers, Jr., Ph.D. is the Founder and CEO of Akers Nanotechnology. He has spent the past 40 years as an innovator in rapid diagnostic test products. In addition, he is a supplier of pharmaceuticals and vaccines. Dr. Akers has taken two of his companies public in the IPO process, one on the NASDAQ and one on the London Stock Exchange's Alternative Investment Market. He holds a doctorate in Neuroscience from Northwestern University and a B.A. in Biology from Saint Joseph's University.
World Fight COVID provides the products and services required for your mission to beat COVID-19.
Follow and Preserve your Immunity with our World Fight COVID Immunity Strategy: Rapid diagnostic self-tests and vaccines for a surveillance program, vaccination campaign, and healthcare delivery in real-time.
https://worldfightcovid.com/
.JPG)